QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2021    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Enzyme-Activated Prodrug-Based Smart Liposomes Specifically Enhance Tumor Hemoperfusion with Efficient Drug Delivery to Pancreatic Cancer Cells and Stellate Cells 期刊论文 ADVANCED FUNCTIONAL MATERIALS, 2021, 页码: 14 作者:  Duan, Nianxiu;  Li, Junjun;  Song, Sha;  Wang, Feng;  Yang, Yiwei 收藏  |  浏览/下载：28/0  |  提交时间：2021/11/04 drug delivery  pancreatic cancer  prodrugs  smart liposomes  tumor-specific vascular promotion   Metal-drug nanoparticles-mediated osteolytic microenvironment regulation for enhanced radiotherapy of orthotopic osteosarcoma 期刊论文 CHEMICAL ENGINEERING JOURNAL, 2021, 卷号: 417, 页码: 11 作者:  Geng, Huan;  Zhou, Mengxue;  Li, Bin;  Liu, Liang;  Yang, Xu 收藏  |  浏览/下载：26/0  |  提交时间：2021/08/17 Metal-drug nanoparticles  Orthotopic osteosarcoma  Osteolytic microenvironment  Zoledronate  Radiotherapy   Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells 期刊论文 THORACIC CANCER, 2021, 页码: 9 作者:  Zhang, Mi;  Quan, Haitian;  Fu, Li;  Li, Yun;  Fu, Haoyu 收藏  |  浏览/下载：21/0  |  提交时间：2021/05/24 EGFR‐  mutant non‐  small cell lung cancer  famitinib  HS‐  10296  multi‐  targeted tyrosine kinase inhibitor  third‐  generation EGFR inhibitor